Indepentednt logo

Lipid lowering: clinical outcome evidence should be followed

Dr Alan BeggDr Alan Begg discusses the latest results from the ENHANCE trial and their implications for the use of ezetimibe

Chair of the SIGN stable angina guideline development group and a member of the SIGN CHD Steering group

Published online: 01 February 2008

Log in or register now for FREE in order to:

  • benefit from unlimited access to all pages, including:
    • 180+ guideline summaries
    • 1000+ evidence-based articles
  • review and leave comments on all articles and summaries
  • automatically track your reading and learning via your CPD tracker
  • on-demand webinars presented by leading clinical experts

Registration only takes 2 minutes and it will give you FREE access to all content across:



Need help? Email us